These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20399219)

  • 1. Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models.
    Choi JK; Carreras I; Dedeoglu A; Jenkins BG
    Neuropharmacology; 2010; 59(4-5):353-7. PubMed ID: 20399219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
    Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the efficacy of a combination Aβ-targeted treatment in a mouse model of Alzheimer's disease.
    Liu M; Jevtic S; Markham-Coultes K; Ellens NPK; O'Reilly MA; Hynynen K; Aubert I; McLaurin J
    Brain Res; 2018 Jan; 1678():138-145. PubMed ID: 29066368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifaceted assessment of the APP/PS1 mouse model for Alzheimer's disease: Applying MRS, DTI, and ASL.
    Shen Z; Lei J; Li X; Wang Z; Bao X; Wang R
    Brain Res; 2018 Nov; 1698():114-120. PubMed ID: 30077647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy in a transgenic model of Alzheimer's disease.
    Aytan N; Choi JK; Carreras I; Kowall NW; Jenkins BG; Dedeoglu A
    Exp Neurol; 2013 Dec; 250():228-238. PubMed ID: 24120437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.
    Chen SQ; Wang PJ; Ten GJ; Zhan W; Li MH; Zang FC
    Dement Geriatr Cogn Disord; 2009; 28(6):558-66. PubMed ID: 20093832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment effects in a transgenic mouse model of Alzheimer's disease: a magnetic resonance spectroscopy study after passive immunization.
    Marjańska M; Weigand SD; Preboske G; Wengenack TM; Chamberlain R; Curran GL; Poduslo JF; Garwood M; Kobayashi D; Lin JC; Jack CR
    Neuroscience; 2014 Feb; 259():94-100. PubMed ID: 24316473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.
    Chen SQ; Cai Q; Shen YY; Wang PJ; Teng GJ; Zhang W; Zang FC
    Behav Brain Res; 2012 Nov; 235(1):1-6. PubMed ID: 22828014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization.
    Teng E; Taylor K; Bilousova T; Weiland D; Pham T; Zuo X; Yang F; Chen PP; Glabe CG; Takacs A; Hoffman DR; Frautschy SA; Cole GM
    Neurobiol Dis; 2015 Oct; 82():552-560. PubMed ID: 26369878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study.
    Barbagallo G; Morelli M; Quattrone A; Chiriaco C; Vaccaro MG; Gullà D; Rocca F; Caracciolo M; Novellino F; Sarica A; Arabia G; Sabatini U; Quattrone A
    Parkinsonism Relat Disord; 2019 May; 62():185-191. PubMed ID: 30558837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment.
    Westman E; Spenger C; Oberg J; Reyer H; Pahnke J; Wahlund LO
    BMC Neurosci; 2009 Apr; 10():33. PubMed ID: 19351388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.
    Snytnikova O; Telegina D; Savina E; Tsentalovich Y; Kolosova N
    J Alzheimers Dis; 2024; 99(s2):S327-S344. PubMed ID: 37980669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Vitamin E Status Dictates Oxidative Stress Outcomes by Modulating Effects of Fish Oil Supplementation in Alzheimer Disease Model APP
    Dong S; Huang X; Zhen J; Van Halm-Lutterodt N; Wang J; Zhou C; Yuan L
    Mol Neurobiol; 2018 Dec; 55(12):9204-9219. PubMed ID: 29656360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease.
    Hawkes CA; Deng LH; Shaw JE; Nitz M; McLaurin J
    Eur J Neurosci; 2010 Jan; 31(2):203-13. PubMed ID: 20074226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice.
    Oberg J; Spenger C; Wang FH; Andersson A; Westman E; Skoglund P; Sunnemark D; Norinder U; Klason T; Wahlund LO; Lindberg M
    Neurobiol Aging; 2008 Sep; 29(9):1423-33. PubMed ID: 17434239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism.
    Viola A; Nicoli F; Denis B; Confort-Gouny S; Le Fur Y; Ranjeva JP; Viout P; Cozzone PJ
    MAGMA; 2004 Sep; 17(1):47-61. PubMed ID: 15340856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1).
    Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A
    J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
    J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.